A Study of Buntanetap in Participants With PD (NCT07284784)
An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Parkinson's Disease
🩺 Plain-English Summary (8th-Grade Level)
This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will be conducted with two cohorts. Cohort 1 will enroll via invitation only for PD participants who have previously participated in buntanetap clinical trials. Cohort 2 will be for PD participants who are receiving deep brain stimulation (DBS) treatment. Qualified participants will receive buntanetap 30mg QD after a screening period of up to 42 days.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 40 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (27 Sites)
Showing the first 25 of 27 sites.
- University of Alabama at Birmingham — Birmingham, Alabama
- Banner Sun Health Research Institute - Cleo Roberts Center for Clinical Research — Sun City, Arizona
- Parkinson's & Movement Disorder Institute (PMDI) - Orange County Office — Fountain Valley, California
- Cenexel Rocky Mountain Clinical Research — Englewood, Colorado
- New England Institute for Clinical Research (Ki Health Partners) — Stamford, Connecticut
- First Choice Neurology - Aventura Neurologic Associates — Aventura, Florida
- Arrow Clinical Trials — Daytona Beach, Florida
- Accel Clinical Sites-Georgia LLC dba Accel Research Sites-Lake Oconee CRU — DeLand, Florida
- Renstar Medical Research — Ocala, Florida
- University of South Florida (USF) - University of South Florida College of Medicine - Parkinson's Di — Tampa, Florida
- Conquest Research — Winter Park, Florida
- iResearch Atlanta — Decatur, Georgia
- Josephson Wallack Munshower Neurology, P.C. — Indianapolis, Indiana
- University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D — Kansas City, Kansas
- Quest Research Institute — Farmington Hills, Michigan
- Mount Sinai Hospital — New York, New York
- Duke Department of Neurosurgery — Durham, North Carolina
- The Ohio State University Wexner Medical Center — Columbus, Ohio
- The Movement Disorder Clinic of Oklahoma — Tulsa, Oklahoma
- Abington Neurology — Willow Grove, Pennsylvania
- Medical University of South Carolina (MUSC) - The Murray Center for Research on Parkinson's Disease — Charleston, South Carolina
- Neurology Clinic, P.C. — Cordova, Tennessee
- Veracity Neuroscience LLC — Memphis, Tennessee
- Central Texas Neurology — Round Rock, Texas
- University of Virginia Health System (UVAHS) - Adult Neurology Clinic — Charlottesville, Virginia
📞 Contact the Study Coordinator
Phone: (484) 875-3192
Email: maccallum@annovisbio.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Parkinson's Disease (PD)
- A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease — Aliso Viejo, California
- IMPACT 360 for Parkinson's Disease — Vancouver, British Columbia
- Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease — Birmingham, Alabama
- AAV2-hAADC for Parkinson's Disease (PDCS-01) — Columbus, Ohio
- Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease — Stanford, California
Explore by condition: All Parkinson's Disease (PD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.